ADVERSE REACTIONS SECTION.
Sincerus Florida, LLC. Adverse reactions. f.
Citing DrugCentral © 2024. License
COMPONENTS.
Active, inactive. f.
Citing DrugCentral © 2024. License
INSTRUCTIONS FOR USE SECTION.
Directions for use. ds.
Citing DrugCentral © 2024. License
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL.
NDC 72934-5071-3 DIBUCAINE HCL USP 0.5% LIDOCAINE USP 15% PHENYLEPHRINE HCL USP 1% PRILOCAINE USP 5%. Ointment 120gm. s.
Citing DrugCentral © 2024. License